II. Clinical Trials, Intervention Trials, Behavior Modification Trials
NCCC has been or would consider being involved in the following:
1. Site/case selection; identification of promising locations for trials through analysis of public cancer registry data
2. Internal identification of physicians that may have patients eligible for a trial
3. Direct work with physicians to enroll patients and retain them in the trial
4. Rapid case ascertainment of cancer patients - population-based participant identification within weeks of diagnosis*
5. Recruitment of underserved populations, such as Vietnamese, Chinese, Hispanic, and other groups
6. Web-based study enrollment, data capture and management
7. Data collection instrument development and validation (both hard-copy and web-based)
8. Processing of data: data cleanup, traceability and auditability of data contained in the case report form (CRF); ensuring databases reflect clean CRFs
9. Development of statistical plans, statistical analysis, and preparation of reports to conform to FDA or other regulatory agency guidelines
* We have the ability to select patients based upon a number of criteria such as: clinical or pathology-based disease characteristics, race/ethnicity, area of residence, age, gender, residence in disadvantaged census tracts, type of treating facility, etc. It is also possible to either include patients from a broad geographic area or restrict patients to those living in the Greater Bay Area. Disease definition and patient inclusion criteria will dictate the size of the geographic area that can be covered.
Back to Guide for Collaborators home page.
NCCC conducts innovative and dynamic cancer research and outreach programs that explore areas with significant impact on reducing the cancer burden. For more information about our research programs or possible collaborations, contact Tim Radak (tradak@nccc.org, 510-608-5026) or Ingrid Oakley-Girvan (ioakley@nccc.org, 510-608-5045).
|
